Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propranolol plasma concentrations and plasmapheresis

R L Talbert, Y Y Wong, D B Duncan

    Drug Intelligence & Clinical Pharmacy
    |December 1, 1981
    PubMed
    Summary

    Plasmapheresis significantly alters propranolol levels in patients with hemolytic-uremic syndrome. This blood purification technique may affect how the body processes propranolol, impacting drug efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Disease-Modifying Antirheumatic Drugs and Dementia Prevention: A Systematic Review of Observational Evidence in Rheumatoid Arthritis.

    The journal of prevention of Alzheimer's disease·2024
    Same author

    The role of platelet-rich plasma in androgenetic alopecia: A systematic review.

    Journal of cosmetic dermatology·2024
    Same author

    Siriraj I <sup>G</sup>γ(<sup>A</sup>γδβ)<sup>0</sup>-thalassaemia causing severe thalassaemia intermedia in compound heterozygous state with IVS1-1(G→T) mutation.

    The Malaysian journal of pathology·2021
    Same author

    Factors influencing patients' hypertension self-management and sustainable self-care practices: a qualitative study.

    Public health·2019
    Same author

    Short- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole treatment in female dogs with uncomplicated bacterial cystitis.

    Journal of veterinary internal medicine·2014
    Same author

    Tears evaluation of one sample of keratoconus patients in kuala lumpur.

    The Medical journal of Malaysia·2013

    Area of Science:

    • Pharmacokinetics
    • Nephrology
    • Critical Care Medicine

    Background:

    • Hemolytic-uremic syndrome (HUS) is a severe condition often requiring renal replacement therapy.
    • Plasmapheresis is a critical treatment for HUS, involving the removal of plasma and its constituents.
    • Propranolol is a beta-blocker frequently used in managing various cardiovascular conditions.

    Observation:

    • Propranolol plasma concentrations were monitored in an HUS patient undergoing plasmapheresis.
    • Measurements were taken before and after plasmapheresis sessions on three separate occasions.
    • Significant alterations in propranolol pharmacokinetics were observed during the procedure.

    Findings:

    • The mean half-life of propranolol was reduced to 25.6% of baseline values during plasmapheresis.
    • The elimination rate constant for propranolol also decreased significantly during plasmapheresis.
    • These pharmacokinetic changes indicate a substantial influence of plasmapheresis on propranolol disposition.

    Implications:

    • Plasmapheresis can markedly alter propranolol pharmacokinetics, potentially affecting therapeutic outcomes.
    • Dosage adjustments for propranolol may be necessary in HUS patients undergoing plasmapheresis.
    • Further research is warranted to fully elucidate the interaction between plasmapheresis and propranolol metabolism.

    Related Experiment Videos